Skip to Content

Lipton Teas and Infusions

« Back to Glossary Index

SUBTOPIC: Woolfson, Daniel (4 July 2022)
– Ekaterra appoints new CEO and chair

SUBTOPIC: Cavale, Siddharth (18 November 2021)
– Unilever bags $5 billion deal with CVC for tea business

SUBTOPIC: Massoudi, Arash; Wiggins, Kaye; Evans, Judith; Gara, Antoine (18 November 2021)
– CVC agrees to €4.5 billion deal to buy Unilever’s tea business

SUBTOPIC: Berry, Kim (6 July 2022)
– Unilever completes sale of tea business

SUBTOPIC: Чай Lipton и Brooke Bond перестанут продавать в России
– rbc.ru (in Russian) 1 August 2022

Lipton Teas and Infusions is a private company based in Rotterdam, Netherlands, that produces tea and other herbal drinks. It was formed in 2021 as a distinct division within Unilever as part of a plan to divest the majority of its tea-making business and was initially named Ekaterra. Unilever retained businesses in India and Indonesia, as well as its Lipton iced tea joint venture with PepsiCo.

Lipton Teas & Infusions
FormerlyEkaterra (2021–2023)
Company typePrivate
IndustryDrink
PredecessorUnilever
Founded2021; 3 years ago (2021)
Headquarters,
Netherlands
Area served
Worldwide
Key people
  • Nathalie Roos (CEO)
  • Pierre Laubies (Chair of the board)
ProductsTea
Brands
OwnerCVC Capital Partners
Number of employees
17,000 (2024)
Websitewww.liptonteas.com

The private equity firm CVC Capital Partners reached an agreement in November 2021 to purchase the division for €4.5 billion. The sale was completed in July 2022.

A month after the sale, the company announced its withdrawal from the Russian market. The current situation in the country "does not allow the company to develop its business steadily", said an Ekaterra spokesman.

« Back to Glossary Index